Navigation Links
One Sigmoidoscopy Boosts Colon Cancer Survival Odds
Date:4/27/2010

Single exam between ages 55 and 64 confers lasting benefit, researchers say

TUESDAY, April 27 (HealthDay News) -- Adults who undergo a sigmoidoscopy examination between ages 55 and 64 could significantly reduce their odds of developing and dying from colorectal cancer, new research shows.

Flexible sigmoidoscopy enables doctors to look for cancers and symptomless growths called adenomas in the rectum and sigmoid (lower) colon, where two-thirds of colorectal cancers occur. Sigmoidoscopy does not examine the upper colon, as colonoscopy does.

Noting that most people with distal colon cancer (rectum and lower colon) will have developed an adenoma by age 60, the researchers theorized that removing adenomas through sigmoidoscopy would provide lasting protection.

In a long-term study, British researchers found that having the cancer-screening test just once in that age range reduced the incidence of colorectal cancer by one-third.

"The results from our trial show that flexible sigmoidoscopy is a safe and practical test and, when offered only once to people between ages 55 and 64 years, confers a substantial and long-lasting protection from colorectal cancer," the authors wrote in a study released online April 27 in advance of publication in an upcoming print issue of The Lancet.

Colorectal cancer is the third most common cancer worldwide (fourth in the United States), resulting in one million diagnoses and 600,000 deaths a year. Survival rates are good for cancers that haven't spread, so early detection is key.

Many countries promote fecal occult blood tests for early screening, but that technique reduces mortality by only 15 percent, according to background information in the study.

For their study, begun nearly 16 years ago and conducted in England, Wales and Scotland, the research team followed almost 113,000 men and women in a control group and another 57,099 participants in an intervention group, of which 40,674 (71 percent) underwent flexible sigmoidoscopy.

Over an average 11 years of follow-up, 2,524 participants were diagnosed with colorectal cancer (1,818 in the control group and 706 in the intervention group). Deaths certified from colorectal cancer totaled 727 (538 in the control group, and 189 in the intervention group), the study authors noted.

Incidence of distal colorectal cancer fell by 50 percent. Cases of colorectal cancer among those screened were reduced by 33 percent and deaths by 43 percent, the authors said.

"Confining results to the rectum and sigmoid (lower) colon, incidence was reduced by half in those who were screened," wrote Wendy Atkin of Imperial College London, and colleagues.

More information

To learn more about flexible sigmoidoscopy, see the U.S. National Institute of Diabetes and Digestive and Kidney Diseases.



-- Margaret Steele



SOURCE: The Lancet, news release, April 27, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Biking to School Boosts Kids Fitness
2. Using Nicotine Patch Longer Boosts Efforts to Quit
3. Original Sewing & Quilt Expo Boosts Benefits
4. New study shows TGen spin-off boosts Scottsdale economy
5. Ageing Demographic Boosts Uptake of Wireless Patient Monitoring Devices Across Europe, Finds Frost & Sullivan
6. Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via
7. Procedure Boosts Outcomes in Implantable Defibrillator Patients
8. A midday nap markedly boosts the brains learning capacity
9. Dry Weather Boosts Odds of Flu Outbreaks
10. Fitness Boosts Brain Power in Multiple Sclerosis Patients
11. Ritalin Boosts Learning by Increasing Brain Plasticity, According to UCSF Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... ... 21, 2017 , ... Pacifica Graduate Institute’s Alumni Association announced ... events for its annual meeting “Coming Home 2017,” an activity-packed weekend of educational ... will be held on Friday January 27 through Sunday, January 29, 2017 at ...
(Date:1/21/2017)... ... January 21, 2017 , ... The Nobel ... Dan Holtzclaw in media for its creos™ line of bone regenerative products. ... Holtzclaw in which he utilizes creos™ allo.gain™ bone graft for a variety of ...
(Date:1/20/2017)... ... January 20, 2017 , ... Source Vitál Apothecary, a skin and ... essential oils, announced the company had a successful visit to the 2017 ECRM Diet, ... gives companies that work in the nutritional, sports and health industries a chance to ...
(Date:1/20/2017)... , ... January 20, 2017 , ... ... products to enhance people’s everyday lives, recently attended the January ECRM Trade Show ... ATP Science is known for its large range of supplements that keep the ...
(Date:1/20/2017)... New York, NY (PRWEB) , ... January 20, ... ... drinks – VW+ 001 and its sugar-free alternative VW+ 002. The drinks have ... the body with optimal conditions to perform during your workout. , After a ...
Breaking Medicine News(10 mins):
(Date:1/20/2017)... Research and Markets has announced the addition of ... report to their offering. ... This research service on the global pharmaceutical stability ... a snapshot of the key participants in the market. ... 2016 to 2020. The market is expected to grow at a ...
(Date:1/19/2017)... LONDON , Jan. 19, 2017 ... 2022 Summary GlobalData,s new report, "Germany Cataract ... data on the Germany Cataract Surgery Devices market. The ... (in units) and average prices (USD) within market segements ... The report also provides company shares and distribution shares ...
(Date:1/19/2017)... WASHINGTON , Jan. 19, 2017 Conference Call and ... VNDA ) today announced it will release results for the ... market closes. ... Vanda will host a conference call at 4:30 PM ET on ... quarter and full year 2016 financial results and other corporate activities. ...
Breaking Medicine Technology: